HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) A correction has been published Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sanchez-Guajardo, V. Articles by Freitas, A. A. Search for Related Content PubMed PubMed Citation Articles by Sanchez-Guajardo, V. Articles by Freitas, A. A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH

Different Competitive Capacities of Stat4- and Stat6-Deficient CD4⁺ T Cells during Lymphophenia-Driven Proliferation¹

Vanesa Sanchez-Guajardo^*, José A. M. Borghans^2,*, Maria-Elena Marquez, Sylvie Garcia^* and Antonio A. Freitas^3,*

^* Lymphocyte Population Biology Unit and Molecular Immunology Unit, Institute Pasteur, Paris, France

The outcome of an immune response relies on the competitive capacities acquired through differentiation of CD4⁺ T cells into Th1 or Th2 effector cells. Because Stat4 and Stat6 proteins are implicated in the Th1 vs Th2 generation and maintenance, respectively, we compare in this study the kinetics of Stat4^–/– and Stat6^–/– CD4⁺ T cells during competitive bone marrow reconstitution and lymphopenia-driven proliferation. After bone marrow transplantation, both populations reconstitute the peripheral T cell pools equally well. After transfer into lymphopenic hosts, wild-type and Stat6^–/– CD4⁺ T cells show a proliferation advantage, which is early associated with the expression of an active phospho-Stat4 and the down-regulation of Stat6. Despite these differences, Stat4- and Stat6-deficient T cells reach similar steady state numbers. However, when both Stat4^–/– and Stat6^–/– CD4⁺ T cells are coinjected into the same hosts, the Stat6^–/– cells become dominant and out-compete Stat4^–/– cells. These findings suggest that cell activation, through the Stat4 pathway and the down-regulation of Stat6, confers to pro-Th1 T cells a slight proliferation advantage that in a competitive situation has major late repercussions, because it modifies the final homeostatic equilibrium of the populations and favors the establishment of Th1 CD4⁺ T cell dominance.

This article has been cited by other articles:

				S. B. S. King, A. M. Knorn, C. Ohnmacht, and D. Voehringer Accumulation of Effector CD4 T Cells during Type 2 Immune Responses Is Negatively Regulated by Stat6 J. Immunol., January 15, 2008; 180(2): 754 - 763. [Abstract] [Full Text] [PDF]

				H. Ji, F. Rintelen, C. Waltzinger, D. Bertschy Meier, A. Bilancio, W. Pearce, E. Hirsch, M. P. Wymann, T. Ruckle, M. Camps, et al. Inactivation of PI3K{gamma} and PI3K{delta} distorts T-cell development and causes multiple organ inflammation Blood, October 15, 2007; 110(8): 2940 - 2947. [Abstract] [Full Text] [PDF]

				V. Sanchez-Guajardo, C. Tanchot, J. T. O'Malley, M. H. Kaplan, S. Garcia, and A. A. Freitas Agonist-Driven Development of CD4+CD25+Foxp3+ Regulatory T Cells Requires a Second Signal Mediated by Stat6 J. Immunol., June 15, 2007; 178(12): 7550 - 7556. [Abstract] [Full Text] [PDF]